Cargando…

A Cross-Sectional Study of Exposure Factors Associated with Seropositivity for SARS-CoV-2 Antibodies during the Second Epidemic Wave among a Sample of the University of Corsica (France)

This study aimed to estimate the seroprevalence of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection within the staff and student populations of the University of Corsica (France) during the second wave of the epidemic. Methods: A cross-sectional survey was conducted from 23 Nov...

Descripción completa

Detalles Bibliográficos
Autores principales: Decarreaux, Dorine, Sevila, Julie, Masse, Shirley, Capai, Lisandru, Fourié, Toscane, Saba Villarroel, Paola Mariela, Amroun, Abdennour, Nurtop, Elif, Vareille, Matthieu, Pouquet, Marie, Blanchon, Thierry, de Lamballerie, Xavier, Charrel, Rémi, Falchi, Alessandra
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8872171/
https://www.ncbi.nlm.nih.gov/pubmed/35206161
http://dx.doi.org/10.3390/ijerph19041953
_version_ 1784657171156303872
author Decarreaux, Dorine
Sevila, Julie
Masse, Shirley
Capai, Lisandru
Fourié, Toscane
Saba Villarroel, Paola Mariela
Amroun, Abdennour
Nurtop, Elif
Vareille, Matthieu
Pouquet, Marie
Blanchon, Thierry
de Lamballerie, Xavier
Charrel, Rémi
Falchi, Alessandra
author_facet Decarreaux, Dorine
Sevila, Julie
Masse, Shirley
Capai, Lisandru
Fourié, Toscane
Saba Villarroel, Paola Mariela
Amroun, Abdennour
Nurtop, Elif
Vareille, Matthieu
Pouquet, Marie
Blanchon, Thierry
de Lamballerie, Xavier
Charrel, Rémi
Falchi, Alessandra
author_sort Decarreaux, Dorine
collection PubMed
description This study aimed to estimate the seroprevalence of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection within the staff and student populations of the University of Corsica (France) during the second wave of the epidemic. Methods: A cross-sectional survey was conducted from 23 November 2020 to 31 January 2021. The participants underwent blood sampling using a fingerstick procedure and completed an anonymized questionnaire. Sera were tested for the presence of anti-SARS-CoV-2 IgG (ELISA-S) and, if positive, with an in-house virus neutralization test (VNT). Results: A total of 418 persons were included in the study. The overall seroprevalence was 12.8% (95% confidence interval (CI), 9.8–16.6%). A total of 15 (31%) of the 49 individuals who had a positive ELISA-S also had a positive VNT. Seropositivity was associated with living at the city campus during the week and on weekends (OR = 3.74 [1.40–12.00]), using public transportation/carpooling (OR = 2.00 [1.01–4.02]), and being in contact with a person who tested positive for SARS-CoV-2 (OR = 2.32 [1.20–4.40]). The main symptoms associated with seropositivity were “having had an acute respiratory infection” (OR = 3.05 [1.43–6.43]) and “experiencing loss of smell” (OR = 16.4 [5.87–50.7]). Conclusion: These results could be useful for SARS-CoV-2 prevention and control on university campuses.
format Online
Article
Text
id pubmed-8872171
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-88721712022-02-25 A Cross-Sectional Study of Exposure Factors Associated with Seropositivity for SARS-CoV-2 Antibodies during the Second Epidemic Wave among a Sample of the University of Corsica (France) Decarreaux, Dorine Sevila, Julie Masse, Shirley Capai, Lisandru Fourié, Toscane Saba Villarroel, Paola Mariela Amroun, Abdennour Nurtop, Elif Vareille, Matthieu Pouquet, Marie Blanchon, Thierry de Lamballerie, Xavier Charrel, Rémi Falchi, Alessandra Int J Environ Res Public Health Article This study aimed to estimate the seroprevalence of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection within the staff and student populations of the University of Corsica (France) during the second wave of the epidemic. Methods: A cross-sectional survey was conducted from 23 November 2020 to 31 January 2021. The participants underwent blood sampling using a fingerstick procedure and completed an anonymized questionnaire. Sera were tested for the presence of anti-SARS-CoV-2 IgG (ELISA-S) and, if positive, with an in-house virus neutralization test (VNT). Results: A total of 418 persons were included in the study. The overall seroprevalence was 12.8% (95% confidence interval (CI), 9.8–16.6%). A total of 15 (31%) of the 49 individuals who had a positive ELISA-S also had a positive VNT. Seropositivity was associated with living at the city campus during the week and on weekends (OR = 3.74 [1.40–12.00]), using public transportation/carpooling (OR = 2.00 [1.01–4.02]), and being in contact with a person who tested positive for SARS-CoV-2 (OR = 2.32 [1.20–4.40]). The main symptoms associated with seropositivity were “having had an acute respiratory infection” (OR = 3.05 [1.43–6.43]) and “experiencing loss of smell” (OR = 16.4 [5.87–50.7]). Conclusion: These results could be useful for SARS-CoV-2 prevention and control on university campuses. MDPI 2022-02-10 /pmc/articles/PMC8872171/ /pubmed/35206161 http://dx.doi.org/10.3390/ijerph19041953 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Decarreaux, Dorine
Sevila, Julie
Masse, Shirley
Capai, Lisandru
Fourié, Toscane
Saba Villarroel, Paola Mariela
Amroun, Abdennour
Nurtop, Elif
Vareille, Matthieu
Pouquet, Marie
Blanchon, Thierry
de Lamballerie, Xavier
Charrel, Rémi
Falchi, Alessandra
A Cross-Sectional Study of Exposure Factors Associated with Seropositivity for SARS-CoV-2 Antibodies during the Second Epidemic Wave among a Sample of the University of Corsica (France)
title A Cross-Sectional Study of Exposure Factors Associated with Seropositivity for SARS-CoV-2 Antibodies during the Second Epidemic Wave among a Sample of the University of Corsica (France)
title_full A Cross-Sectional Study of Exposure Factors Associated with Seropositivity for SARS-CoV-2 Antibodies during the Second Epidemic Wave among a Sample of the University of Corsica (France)
title_fullStr A Cross-Sectional Study of Exposure Factors Associated with Seropositivity for SARS-CoV-2 Antibodies during the Second Epidemic Wave among a Sample of the University of Corsica (France)
title_full_unstemmed A Cross-Sectional Study of Exposure Factors Associated with Seropositivity for SARS-CoV-2 Antibodies during the Second Epidemic Wave among a Sample of the University of Corsica (France)
title_short A Cross-Sectional Study of Exposure Factors Associated with Seropositivity for SARS-CoV-2 Antibodies during the Second Epidemic Wave among a Sample of the University of Corsica (France)
title_sort cross-sectional study of exposure factors associated with seropositivity for sars-cov-2 antibodies during the second epidemic wave among a sample of the university of corsica (france)
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8872171/
https://www.ncbi.nlm.nih.gov/pubmed/35206161
http://dx.doi.org/10.3390/ijerph19041953
work_keys_str_mv AT decarreauxdorine acrosssectionalstudyofexposurefactorsassociatedwithseropositivityforsarscov2antibodiesduringthesecondepidemicwaveamongasampleoftheuniversityofcorsicafrance
AT sevilajulie acrosssectionalstudyofexposurefactorsassociatedwithseropositivityforsarscov2antibodiesduringthesecondepidemicwaveamongasampleoftheuniversityofcorsicafrance
AT masseshirley acrosssectionalstudyofexposurefactorsassociatedwithseropositivityforsarscov2antibodiesduringthesecondepidemicwaveamongasampleoftheuniversityofcorsicafrance
AT capailisandru acrosssectionalstudyofexposurefactorsassociatedwithseropositivityforsarscov2antibodiesduringthesecondepidemicwaveamongasampleoftheuniversityofcorsicafrance
AT fourietoscane acrosssectionalstudyofexposurefactorsassociatedwithseropositivityforsarscov2antibodiesduringthesecondepidemicwaveamongasampleoftheuniversityofcorsicafrance
AT sabavillarroelpaolamariela acrosssectionalstudyofexposurefactorsassociatedwithseropositivityforsarscov2antibodiesduringthesecondepidemicwaveamongasampleoftheuniversityofcorsicafrance
AT amrounabdennour acrosssectionalstudyofexposurefactorsassociatedwithseropositivityforsarscov2antibodiesduringthesecondepidemicwaveamongasampleoftheuniversityofcorsicafrance
AT nurtopelif acrosssectionalstudyofexposurefactorsassociatedwithseropositivityforsarscov2antibodiesduringthesecondepidemicwaveamongasampleoftheuniversityofcorsicafrance
AT vareillematthieu acrosssectionalstudyofexposurefactorsassociatedwithseropositivityforsarscov2antibodiesduringthesecondepidemicwaveamongasampleoftheuniversityofcorsicafrance
AT pouquetmarie acrosssectionalstudyofexposurefactorsassociatedwithseropositivityforsarscov2antibodiesduringthesecondepidemicwaveamongasampleoftheuniversityofcorsicafrance
AT blanchonthierry acrosssectionalstudyofexposurefactorsassociatedwithseropositivityforsarscov2antibodiesduringthesecondepidemicwaveamongasampleoftheuniversityofcorsicafrance
AT delamballeriexavier acrosssectionalstudyofexposurefactorsassociatedwithseropositivityforsarscov2antibodiesduringthesecondepidemicwaveamongasampleoftheuniversityofcorsicafrance
AT charrelremi acrosssectionalstudyofexposurefactorsassociatedwithseropositivityforsarscov2antibodiesduringthesecondepidemicwaveamongasampleoftheuniversityofcorsicafrance
AT falchialessandra acrosssectionalstudyofexposurefactorsassociatedwithseropositivityforsarscov2antibodiesduringthesecondepidemicwaveamongasampleoftheuniversityofcorsicafrance
AT decarreauxdorine crosssectionalstudyofexposurefactorsassociatedwithseropositivityforsarscov2antibodiesduringthesecondepidemicwaveamongasampleoftheuniversityofcorsicafrance
AT sevilajulie crosssectionalstudyofexposurefactorsassociatedwithseropositivityforsarscov2antibodiesduringthesecondepidemicwaveamongasampleoftheuniversityofcorsicafrance
AT masseshirley crosssectionalstudyofexposurefactorsassociatedwithseropositivityforsarscov2antibodiesduringthesecondepidemicwaveamongasampleoftheuniversityofcorsicafrance
AT capailisandru crosssectionalstudyofexposurefactorsassociatedwithseropositivityforsarscov2antibodiesduringthesecondepidemicwaveamongasampleoftheuniversityofcorsicafrance
AT fourietoscane crosssectionalstudyofexposurefactorsassociatedwithseropositivityforsarscov2antibodiesduringthesecondepidemicwaveamongasampleoftheuniversityofcorsicafrance
AT sabavillarroelpaolamariela crosssectionalstudyofexposurefactorsassociatedwithseropositivityforsarscov2antibodiesduringthesecondepidemicwaveamongasampleoftheuniversityofcorsicafrance
AT amrounabdennour crosssectionalstudyofexposurefactorsassociatedwithseropositivityforsarscov2antibodiesduringthesecondepidemicwaveamongasampleoftheuniversityofcorsicafrance
AT nurtopelif crosssectionalstudyofexposurefactorsassociatedwithseropositivityforsarscov2antibodiesduringthesecondepidemicwaveamongasampleoftheuniversityofcorsicafrance
AT vareillematthieu crosssectionalstudyofexposurefactorsassociatedwithseropositivityforsarscov2antibodiesduringthesecondepidemicwaveamongasampleoftheuniversityofcorsicafrance
AT pouquetmarie crosssectionalstudyofexposurefactorsassociatedwithseropositivityforsarscov2antibodiesduringthesecondepidemicwaveamongasampleoftheuniversityofcorsicafrance
AT blanchonthierry crosssectionalstudyofexposurefactorsassociatedwithseropositivityforsarscov2antibodiesduringthesecondepidemicwaveamongasampleoftheuniversityofcorsicafrance
AT delamballeriexavier crosssectionalstudyofexposurefactorsassociatedwithseropositivityforsarscov2antibodiesduringthesecondepidemicwaveamongasampleoftheuniversityofcorsicafrance
AT charrelremi crosssectionalstudyofexposurefactorsassociatedwithseropositivityforsarscov2antibodiesduringthesecondepidemicwaveamongasampleoftheuniversityofcorsicafrance
AT falchialessandra crosssectionalstudyofexposurefactorsassociatedwithseropositivityforsarscov2antibodiesduringthesecondepidemicwaveamongasampleoftheuniversityofcorsicafrance